Hoshi Iryo-Sanki (7634) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 FY2025 was ¥3,594 million, up 7.7% year-over-year, but operating profit fell 22.7% to ¥305 million and net profit attributable to shareholders dropped 23.0% to ¥212 million.

• The company prioritized stable supply of products and services, safety, and social responsibility in the medical, nursing, and welfare sectors.

Financial highlights

• Gross profit for Q1 FY2025 was ¥1,802 million, up from ¥1,627 million year-over-year.

• Operating profit decreased to ¥305 million (down 22.7%), ordinary profit to ¥319 million (down 21.7%), and net profit to ¥212 million (down 23.0%) compared to the same quarter last year.

• EPS for Q1 FY2025 was ¥68.13, down from ¥88.60 year-over-year.

• Comprehensive income for the quarter was ¥381 million, down 16.4% year-over-year.

Outlook and guidance

• Full-year FY2025 guidance remains unchanged: revenue ¥15,000 million (+1.5%), operating profit ¥950 million (+4.7%), net profit ¥1,420 million (+1.9%), and EPS ¥455.74.

• Interim dividend forecast is ¥35 per share, with a full-year dividend of ¥70 per share.